ZA905182B - Low viscosity,highly concentrated surfactant suspension - Google Patents

Low viscosity,highly concentrated surfactant suspension

Info

Publication number
ZA905182B
ZA905182B ZA905182A ZA905182A ZA905182B ZA 905182 B ZA905182 B ZA 905182B ZA 905182 A ZA905182 A ZA 905182A ZA 905182 A ZA905182 A ZA 905182A ZA 905182 B ZA905182 B ZA 905182B
Authority
ZA
South Africa
Prior art keywords
low viscosity
highly concentrated
concentrated surfactant
surfactant suspension
surfactant
Prior art date
Application number
ZA905182A
Other languages
English (en)
Inventor
Bernd Disse
Disse Bernd
Eberhard Weller
Weller Eberhard
Robert Becker
Becker Robert
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA905182B publication Critical patent/ZA905182B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
ZA905182A 1989-07-04 1990-07-03 Low viscosity,highly concentrated surfactant suspension ZA905182B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension

Publications (1)

Publication Number Publication Date
ZA905182B true ZA905182B (en) 1992-03-25

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA905182A ZA905182B (en) 1989-07-04 1990-07-03 Low viscosity,highly concentrated surfactant suspension

Country Status (24)

Country Link
US (1) US5552161A (fr)
EP (1) EP0406732B1 (fr)
JP (1) JP3103582B2 (fr)
KR (1) KR0162642B1 (fr)
AT (1) ATE122891T1 (fr)
AU (1) AU623538B2 (fr)
CA (1) CA2020209C (fr)
DD (1) DD297916A5 (fr)
DE (2) DE3921954A1 (fr)
DK (1) DK0406732T3 (fr)
ES (1) ES2072940T3 (fr)
FI (1) FI95655C (fr)
HK (1) HK1000277A1 (fr)
HU (1) HU205004B (fr)
IE (1) IE68448B1 (fr)
IL (1) IL94961A (fr)
NO (1) NO180620C (fr)
NZ (2) NZ242869A (fr)
PH (1) PH30232A (fr)
PL (1) PL164434B1 (fr)
PT (1) PT94574B (fr)
RU (1) RU2077880C1 (fr)
UA (1) UA26313A (fr)
ZA (1) ZA905182B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
EP1249244A1 (fr) * 2001-04-13 2002-10-16 Universiteit Gent Compositions thérapeutiques pour le traitement d'une maladie influencée par l'équilibre G-actin / F-actin, p.e. une maladie respiratoire
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
JP4734328B2 (ja) * 2005-05-11 2011-07-27 ヤマサ醤油株式会社 肺サーファクタント蛋白質の安定化法
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
DE3369644D1 (en) * 1982-11-22 1987-03-12 Teijin Ltd Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
NO180620C (no) 1997-05-21
NO902961L (no) 1991-01-07
DD297916A5 (de) 1992-01-30
IL94961A0 (en) 1991-06-10
PL164434B1 (pl) 1994-07-29
UA26313A (uk) 1999-08-30
ES2072940T3 (es) 1995-08-01
PT94574A (pt) 1991-03-20
DE3921954A1 (de) 1991-01-17
HUT56274A (en) 1991-08-28
US5552161A (en) 1996-09-03
NO180620B (no) 1997-02-10
DK0406732T3 (da) 1995-10-02
JPH0344332A (ja) 1991-02-26
PH30232A (en) 1997-02-05
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
ATE122891T1 (de) 1995-06-15
HU205004B (en) 1992-03-30
AU623538B2 (en) 1992-05-14
EP0406732B1 (fr) 1995-05-24
NO902961D0 (no) 1990-07-03
FI95655B (fi) 1995-11-30
EP0406732A3 (en) 1991-02-27
NZ234341A (en) 1992-07-28
FI95655C (fi) 1996-03-11
AU5867690A (en) 1991-01-10
KR910002427A (ko) 1991-02-25
KR0162642B1 (ko) 1998-12-01
CA2020209C (fr) 2000-09-12
IE902408A1 (en) 1991-06-19
PT94574B (pt) 1997-02-28
IE68448B1 (en) 1996-06-26
HK1000277A1 (en) 1998-02-20
EP0406732A2 (fr) 1991-01-09
HU904077D0 (en) 1990-12-28
JP3103582B2 (ja) 2000-10-30
NZ242869A (en) 1997-05-26
RU2077880C1 (ru) 1997-04-27
DE59009113D1 (de) 1995-06-29
CA2020209A1 (fr) 1991-01-05

Similar Documents

Publication Publication Date Title
TW329059B (en) Silica
ES8607727A1 (es) Procedimiento para la estabilizacion de preparados farmaceuticos en forma de suspensiones conteniendo sucralfato
ES2064634T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
BG105391A (en) Storable concentrate of formoterol active substance
ZA905182B (en) Low viscosity,highly concentrated surfactant suspension
GEP19971155B (en) Contrast medium and method for its production
GR3007326T3 (fr)
GB8701491D0 (en) Aqueous suspensions of calcium
EP2241329A3 (fr) Anticorps anti-interleukin-9 ou anticorps du récepteur anti-interleukin-9 pour le traitment de la hyper-réponse bronchique
GR3002388T3 (en) Stable aqueous suspension concentrate composition
IL142220A0 (en) Method of treating viral hemorrhagic fever
AU589970B2 (en) Animal litter and process for the production thereof
FR2677351B1 (fr) Suspension aqueuse concentree d'hydrate de calcium et son procede de preparation.
PT76268A (fr) Procede pour la realisation d'un melange pour la preparation de compositions pour l'absorption et l'accumulation de calories
AU3703795A (en) Chondrocyte cell-lines
PL272154A1 (en) Apparatus for aqueous suspension and solution of calcium in particular of quicklime
BG50666A1 (en) Means for soft leather filling
GB2228399B (en) Process for enhancing the perceived strength of tobacco smoke
CS275419B2 (en) Suspension of locomotive's middle bogie with body
EG18716A (en) Aqueous suspension concentrate compositions
PT101461A (pt) Nutriente liquido para recem-nascidos nutriente liquido para recem-nascidos
AU112023S (en) Cloth hanger
BG38689A1 (en) Method for preparing and purifying of finely dispersed aqueous suspension of calcium hydroxide
IT1270647B (it) Soluzioni per il trattamento di stati di shock in particolare shock emorragico
IT1253704B (it) Soluzioni terapeutiche stabili per uso iniettabile a base di fruttosio-1,6-difosfato sale di sodio o di calcio o di magnesio